Skip to main content
Erschienen in: Osteoporosis International 7/2021

18.01.2021 | Original Article

Vertebral fractures are increased in rheumatoid arthritis despite recent therapeutic advances: a case-control study

verfasst von: N. Guañabens, J. M. Olmos, J. L. Hernández, D. Cerdà, C. Hidalgo Calleja, J. A. Martinez López, L. Arboleya, F. J. Aguilar del Rey, S. Martinez Pardo, I. Ros Vilamajó, X. Suris Armangué, D. Grados, C. Beltrán Audera, E. Suero-Rosario, I. Gómez Gracia, A. Salmoral Chamizo, I. Martín-Esteve, H. Florez, A. Naranjo, S. Castañeda, S. Ojeda Bruno, S. García Carazo, A. García Vadillo, L. López Vives, À. Martínez-Ferrer, H. Borrell Paños, P. Aguado Acín, R. Castellanos-Moreira, C. Tebé, C. Gómez-Vaquero, for the OsteoResSer Working Group of the Spanish Society of Rheumatology

Erschienen in: Osteoporosis International | Ausgabe 7/2021

Einloggen, um Zugang zu erhalten

Abstract

Summary

Prevalence and risk factors of vertebral fractures in postmenopausal RA women were assessed in 323 patients and compared with 660 age-matched women. Of patients, 24.15% had at least one vertebral fracture vs.16.06% of controls. Age, glucocorticoids and falls were the main fracture risks. Vertebral fractures were associated with disease severity.

Introduction

There is little quality data on the updated prevalence of fractures in rheumatoid arthritis (RA) that may have changed due to advances in the therapeutic strategy in recent years. This study was aimed at analysing the prevalence and risk factors of vertebral fractures in postmenopausal women with RA and comparing it with that of the general population.

Methods

We included 323 postmenopausal women diagnosed with RA from 19 Spanish Rheumatology Departments, randomly selected and recruited in 2018. Lateral radiographs of the thoracic and lumbar spine were obtained to evaluate morphometric vertebral fractures and the spinal deformity index. We analysed subject characteristics, factors related to RA, and fracture risk factors. The control group consisted of 660 age-matched Spanish postmenopausal women from the population-based Camargo cohort.

Results

Seventy-eight (24.15%) RA patients had at least one vertebral fracture. RA patients had increased fracture risk compared with controls (106 of 660, 16.06%) (p = 0.02). Logistic regression analysis showed that age (OR 2.17; 95% CI 1.27–4.00), glucocorticoids (OR 3.83; 95% CI 1.32–14.09) and falls (OR 3.57; 95% CI 1.91–6.86) were the independent predictors of vertebral fractures in RA patients. The subgroup with vertebral fractures had higher disease activity (DAS28: 3.15 vs. 2.78, p = 0.038) and disability (HAQ: 0.96 vs. 0.63, p = 0.049), as compared with those without vertebral fractures.

Conclusion

The risk of vertebral fracture in RA is still high in recent years, when compared with the general population. The key determinants of fracture risk are age, glucocorticoids and falls. Patients with vertebral fractures have a more severe RA.
Literatur
1.
Zurück zum Zitat Amin S, Gabriel SE, Achenbach SJ, Atkinson EJ, Melton LJ 3rd. (2013) Are young women and men with rheumatoid arthritis at risk for fragility fractures? A population-based study. J Rheumatol 40(10):1669–1676PubMedPubMedCentral Amin S, Gabriel SE, Achenbach SJ, Atkinson EJ, Melton LJ 3rd. (2013) Are young women and men with rheumatoid arthritis at risk for fragility fractures? A population-based study. J Rheumatol 40(10):1669–1676PubMedPubMedCentral
2.
Zurück zum Zitat Kim SY, Schneeweiss S, Liu J, Daniel GW, Chang CL, Garneau K et al (2010) Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis. Arthritis Res Ther 12(4):R154PubMedPubMedCentral Kim SY, Schneeweiss S, Liu J, Daniel GW, Chang CL, Garneau K et al (2010) Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis. Arthritis Res Ther 12(4):R154PubMedPubMedCentral
3.
Zurück zum Zitat van Staa TP, Geusens P, Bijlsma JW, Leufkens HG, Cooper C (2006) Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 54(10):3104–3112PubMed van Staa TP, Geusens P, Bijlsma JW, Leufkens HG, Cooper C (2006) Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 54(10):3104–3112PubMed
4.
Zurück zum Zitat Xue AL, Wu SY, Jiang L, Feng AM, Guo HF, Zhao P (2017) Bone fracture risk in patients with rheumatoid arthritis: a meta-analysis. Medicine (Baltimore) 96(36):e6983 Xue AL, Wu SY, Jiang L, Feng AM, Guo HF, Zhao P (2017) Bone fracture risk in patients with rheumatoid arthritis: a meta-analysis. Medicine (Baltimore) 96(36):e6983
5.
Zurück zum Zitat Tong JJ, Xu SQ, Zong HX, Pan MJ, Teng YZ, Xu JH (2020) Prevalence and risk factors associated with vertebral osteoporotic fractures in patients with rheumatoid arthritis [published correction appears in Clin Rheumatol. 2020 Jun;39(6):2023]. Clin Rheumatol 39(2):357–364PubMed Tong JJ, Xu SQ, Zong HX, Pan MJ, Teng YZ, Xu JH (2020) Prevalence and risk factors associated with vertebral osteoporotic fractures in patients with rheumatoid arthritis [published correction appears in Clin Rheumatol. 2020 Jun;39(6):2023]. Clin Rheumatol 39(2):357–364PubMed
6.
Zurück zum Zitat Buehring B, Thomas J, Wittkämper T, Baraliakos X, Braun J (2020) Evaluation of the trabecular bone score (TBS) in routine clinical care of patients with inflammatory rheumatic and non-inflammatory diseases: correlation with conventional bone mineral density measurement and prevalence of vertebral fractures. Z Rheumatol. https://doi.org/10.1007/s00393-020-00764-9 Buehring B, Thomas J, Wittkämper T, Baraliakos X, Braun J (2020) Evaluation of the trabecular bone score (TBS) in routine clinical care of patients with inflammatory rheumatic and non-inflammatory diseases: correlation with conventional bone mineral density measurement and prevalence of vertebral fractures. Z Rheumatol. https://​doi.​org/​10.​1007/​s00393-020-00764-9
7.
Zurück zum Zitat Dubrovsky AM, Lim MJ, Lane NE (2018) Osteoporosis in rheumatic diseases: anti-rheumatic drugs and the skeleton. Calcif Tissue Int 102(5):607–618PubMed Dubrovsky AM, Lim MJ, Lane NE (2018) Osteoporosis in rheumatic diseases: anti-rheumatic drugs and the skeleton. Calcif Tissue Int 102(5):607–618PubMed
8.
Zurück zum Zitat Ricciardi BF, Paul J, Kim A, Russell LA, Lane JM (2013) Osteoporosis drug therapy strategies in the setting of disease-modifying agents for autoimmune disease. Osteoporos Int 24(2):423–432PubMed Ricciardi BF, Paul J, Kim A, Russell LA, Lane JM (2013) Osteoporosis drug therapy strategies in the setting of disease-modifying agents for autoimmune disease. Osteoporos Int 24(2):423–432PubMed
9.
Zurück zum Zitat Briot K, Rouanet S, Schaeverbeke T, Etchepare F, Gaudin P, Perdriger A et al (2015) The effect of tocilizumab on bone mineral density, serum levels of Dickkopf-1 and bone remodeling markers in patients with rheumatoid arthritis. Joint Bone Spine 82(2):109–115PubMed Briot K, Rouanet S, Schaeverbeke T, Etchepare F, Gaudin P, Perdriger A et al (2015) The effect of tocilizumab on bone mineral density, serum levels of Dickkopf-1 and bone remodeling markers in patients with rheumatoid arthritis. Joint Bone Spine 82(2):109–115PubMed
10.
Zurück zum Zitat Hauser B, Riches PL, Wilson JF, Horne AE, Ralston SH (2014) Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis. Rheumatology (Oxford) 53(10):1759–1766 Hauser B, Riches PL, Wilson JF, Horne AE, Ralston SH (2014) Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis. Rheumatology (Oxford) 53(10):1759–1766
11.
Zurück zum Zitat Siu S, Haraoui B, Bissonnette R, Bessette L, Roubille C, Richer V et al (2015) Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trials. Arthritis Care Res (Hoboken). 67(6):754–764PubMed Siu S, Haraoui B, Bissonnette R, Bessette L, Roubille C, Richer V et al (2015) Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trials. Arthritis Care Res (Hoboken). 67(6):754–764PubMed
12.
Zurück zum Zitat Kawai VK, Grijalva CG, Arbogast PG, Curtis JR, Solomon DH, Delzell E et al (2013) Initiation of tumor necrosis factor α antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseases. Arthritis Care Res (Hoboken) 65(7):1085–1094 Kawai VK, Grijalva CG, Arbogast PG, Curtis JR, Solomon DH, Delzell E et al (2013) Initiation of tumor necrosis factor α antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseases. Arthritis Care Res (Hoboken) 65(7):1085–1094
13.
Zurück zum Zitat Ozen G, Pedro S, Wolfe F, Michaud K (2019) Medications associated with fracture risk in patients with rheumatoid arthritis. Ann Rheum Dis 78(8):1041–1047PubMed Ozen G, Pedro S, Wolfe F, Michaud K (2019) Medications associated with fracture risk in patients with rheumatoid arthritis. Ann Rheum Dis 78(8):1041–1047PubMed
14.
Zurück zum Zitat Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative [published correction appears in Ann Rheum Dis. 2010 Oct;69(10):1892]. Ann Rheum Dis 69(9):1580–1588PubMed Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative [published correction appears in Ann Rheum Dis. 2010 Oct;69(10):1892]. Ann Rheum Dis 69(9):1580–1588PubMed
15.
Zurück zum Zitat Martínez J, Olmos JM, Hernández JL, Pinedo G, Llorca J, Obregón E et al (2009) Bone turnover markers in Spanish postmenopausal women: the Camargo cohort study. Clin Chim Acta 409(1-2):70–74PubMed Martínez J, Olmos JM, Hernández JL, Pinedo G, Llorca J, Obregón E et al (2009) Bone turnover markers in Spanish postmenopausal women: the Camargo cohort study. Clin Chim Acta 409(1-2):70–74PubMed
16.
Zurück zum Zitat Olmos JM, Hernández JL, García-Velasco P, Martínez J, Llorca J, González-Macías J (2016) Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults. Osteoporos Int 27(1):105–113PubMed Olmos JM, Hernández JL, García-Velasco P, Martínez J, Llorca J, González-Macías J (2016) Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults. Osteoporos Int 27(1):105–113PubMed
17.
Zurück zum Zitat Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8(9):1137–1148PubMed Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8(9):1137–1148PubMed
18.
Zurück zum Zitat Kerkeni S, Kolta S, Fechtenbaum J, Roux C (2009) Spinal deformity index (SDI) is a good predictor of incident vertebral fractures. Osteoporos Int 20(9):1547–1552PubMed Kerkeni S, Kolta S, Fechtenbaum J, Roux C (2009) Spinal deformity index (SDI) is a good predictor of incident vertebral fractures. Osteoporos Int 20(9):1547–1552PubMed
19.
Zurück zum Zitat Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 4(6):368–381PubMed Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 4(6):368–381PubMed
20.
Zurück zum Zitat Zerbini CAF, Clark P, Mendez-Sanchez L, Pereira RMR, Messina OD, Uña CR et al (2017) Biologic therapies and bone loss in rheumatoid arthritis. Osteoporos Int 28(2):429–446PubMed Zerbini CAF, Clark P, Mendez-Sanchez L, Pereira RMR, Messina OD, Uña CR et al (2017) Biologic therapies and bone loss in rheumatoid arthritis. Osteoporos Int 28(2):429–446PubMed
22.
Zurück zum Zitat Nyhäll-Wåhlin BM, Ajeganova S, Petersson IF, Andersson M (2019) Increased risk of osteoporotic fractures in Swedish patients with rheumatoid arthritis despite early treatment with potent disease-modifying anti-rheumatic drugs: a prospective general population-matched cohort study. Scand J Rheumatol 48(6):431–438PubMed Nyhäll-Wåhlin BM, Ajeganova S, Petersson IF, Andersson M (2019) Increased risk of osteoporotic fractures in Swedish patients with rheumatoid arthritis despite early treatment with potent disease-modifying anti-rheumatic drugs: a prospective general population-matched cohort study. Scand J Rheumatol 48(6):431–438PubMed
23.
Zurück zum Zitat Mazzucchelli R, Pérez Fernandez E, Crespí-Villarías N, Quirós-Donate J, García Vadillo A, Espinosa M et al (2018) Trends in hip fracture in patients with rheumatoid arthritis: results from the Spanish National Inpatient Registry over a 17-year period (1999-2015). TREND-AR study. RMD Open 4(1):e000671PubMedPubMedCentral Mazzucchelli R, Pérez Fernandez E, Crespí-Villarías N, Quirós-Donate J, García Vadillo A, Espinosa M et al (2018) Trends in hip fracture in patients with rheumatoid arthritis: results from the Spanish National Inpatient Registry over a 17-year period (1999-2015). TREND-AR study. RMD Open 4(1):e000671PubMedPubMedCentral
24.
Zurück zum Zitat Mazzucchelli R, Pérez Fernández E, Crespí Villarías N, Tejedor Alonso MÁ, Sáez López P et al (2019) East-west gradient in hip fracture incidence in Spain: how much can we explain by following the pattern of risk factors? Arch Osteoporos 14(1):115PubMed Mazzucchelli R, Pérez Fernández E, Crespí Villarías N, Tejedor Alonso MÁ, Sáez López P et al (2019) East-west gradient in hip fracture incidence in Spain: how much can we explain by following the pattern of risk factors? Arch Osteoporos 14(1):115PubMed
25.
Zurück zum Zitat Pueyo-Sánchez MJ, Larrosa M, Suris X, Casado E, Auleda J, Fusté J et al (2017) Secular trend in the incidence of hip fracture in Catalonia, Spain, 2003-2014. Age Ageing 46(2):324–328PubMed Pueyo-Sánchez MJ, Larrosa M, Suris X, Casado E, Auleda J, Fusté J et al (2017) Secular trend in the incidence of hip fracture in Catalonia, Spain, 2003-2014. Age Ageing 46(2):324–328PubMed
26.
Zurück zum Zitat Soukola SK, Jämsen ERK, Pauniaho SLK, Ukkonen MT (2020) A population-based study of 2347 fall-related injuries among older people in a Finnish emergency department. Eur Geriatr Med 11(2):315–320PubMed Soukola SK, Jämsen ERK, Pauniaho SLK, Ukkonen MT (2020) A population-based study of 2347 fall-related injuries among older people in a Finnish emergency department. Eur Geriatr Med 11(2):315–320PubMed
27.
Zurück zum Zitat Armstrong C, Swarbrick CM, Pye SR, O'Neill TW (2005) Occurrence and risk factors for falls in rheumatoid arthritis. Ann Rheum Dis 64(11):1602–1604PubMedPubMedCentral Armstrong C, Swarbrick CM, Pye SR, O'Neill TW (2005) Occurrence and risk factors for falls in rheumatoid arthritis. Ann Rheum Dis 64(11):1602–1604PubMedPubMedCentral
28.
Zurück zum Zitat Clynes MA, Jameson K, Prieto-Alhambra D, Harvey NC, Cooper C, Dennison EM (2019) Impact of rheumatoid arthritis and its management on falls, fracture and bone mineral density in UK Biobank. Front Endocrinol (Lausanne) 10:817 Clynes MA, Jameson K, Prieto-Alhambra D, Harvey NC, Cooper C, Dennison EM (2019) Impact of rheumatoid arthritis and its management on falls, fracture and bone mineral density in UK Biobank. Front Endocrinol (Lausanne) 10:817
29.
Zurück zum Zitat Vis M, Havaardsholm EA, Haugeberg G, Uhlig T, Voskuyl AE, van de Stadt RJ et al (2006) Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis. Ann Rheum Dis 65(11):1495–1499PubMedPubMedCentral Vis M, Havaardsholm EA, Haugeberg G, Uhlig T, Voskuyl AE, van de Stadt RJ et al (2006) Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis. Ann Rheum Dis 65(11):1495–1499PubMedPubMedCentral
30.
Zurück zum Zitat Stemmler F, Simon D, Liphardt AM, Englbrecht M, Rech J, Hueber AJ et al (2018) Biomechanical properties of bone are impaired in patients with ACPA-positive rheumatoid arthritis and associated with the occurrence of fractures. Ann Rheum Dis 77(7):973–980PubMedPubMedCentral Stemmler F, Simon D, Liphardt AM, Englbrecht M, Rech J, Hueber AJ et al (2018) Biomechanical properties of bone are impaired in patients with ACPA-positive rheumatoid arthritis and associated with the occurrence of fractures. Ann Rheum Dis 77(7):973–980PubMedPubMedCentral
31.
Zurück zum Zitat Bugatti S, Bogliolo L, Vitolo B, Manzo A, Montecucco C, Caporali R (2016) Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis. Arthritis Res Ther 18(1):226PubMedPubMedCentral Bugatti S, Bogliolo L, Vitolo B, Manzo A, Montecucco C, Caporali R (2016) Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis. Arthritis Res Ther 18(1):226PubMedPubMedCentral
32.
Zurück zum Zitat Kim D, Cho SK, Park B, Jang EJ, Bae SC, Sung YK (2018) Glucocorticoids are associated with an increased risk for vertebral fracture in patients with rheumatoid arthritis. J Rheumatol 45(5):612–620PubMed Kim D, Cho SK, Park B, Jang EJ, Bae SC, Sung YK (2018) Glucocorticoids are associated with an increased risk for vertebral fracture in patients with rheumatoid arthritis. J Rheumatol 45(5):612–620PubMed
33.
Zurück zum Zitat Wang Y, Zhao R, Gu Z, Dong C, Guo G, Li L (2020) Effects of glucocorticoids on osteoporosis in rheumatoid arthritis: a systematic review and meta-analysis. Osteoporos Int 31(8):1401–1409PubMed Wang Y, Zhao R, Gu Z, Dong C, Guo G, Li L (2020) Effects of glucocorticoids on osteoporosis in rheumatoid arthritis: a systematic review and meta-analysis. Osteoporos Int 31(8):1401–1409PubMed
34.
Zurück zum Zitat Ibañez M, Ortiz AM, Castrejón I, Garcia-Vadillo JA, Carvajal I, Castañeda S et al (2010) A rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass. Arthritis Res Ther 12(2):R50PubMedPubMedCentral Ibañez M, Ortiz AM, Castrejón I, Garcia-Vadillo JA, Carvajal I, Castañeda S et al (2010) A rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass. Arthritis Res Ther 12(2):R50PubMedPubMedCentral
35.
Zurück zum Zitat Sambrook PN, Cohen ML, Eisman JA, Pocock NA, Champion GD, Yeates MG (1989) Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study. Ann Rheum Dis 48(7):535–538PubMedPubMedCentral Sambrook PN, Cohen ML, Eisman JA, Pocock NA, Champion GD, Yeates MG (1989) Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study. Ann Rheum Dis 48(7):535–538PubMedPubMedCentral
36.
Zurück zum Zitat Habib GS, Haj S (2005) Bone mineral density in patients with early rheumatoid arthritis treated with corticosteroids. Clin Rheumatol 24(2):129–133PubMed Habib GS, Haj S (2005) Bone mineral density in patients with early rheumatoid arthritis treated with corticosteroids. Clin Rheumatol 24(2):129–133PubMed
37.
Zurück zum Zitat Güler-Yüksel M, Hoes JN, Bultink IEM, Lems WF (2018) Glucocorticoids, inflammation and bone. Calcif Tissue Int 102(5):592–606PubMed Güler-Yüksel M, Hoes JN, Bultink IEM, Lems WF (2018) Glucocorticoids, inflammation and bone. Calcif Tissue Int 102(5):592–606PubMed
38.
Zurück zum Zitat Blavnsfeldt AG, de Thurah A, Thomsen MD, Tarp S, Langdahl B, Hauge EM (2018) The effect of glucocorticoids on bone mineral density in patients with rheumatoid arthritis: a systematic review and meta-analysis of randomized, controlled trials. Bone. 114:172–180PubMed Blavnsfeldt AG, de Thurah A, Thomsen MD, Tarp S, Langdahl B, Hauge EM (2018) The effect of glucocorticoids on bone mineral density in patients with rheumatoid arthritis: a systematic review and meta-analysis of randomized, controlled trials. Bone. 114:172–180PubMed
39.
Zurück zum Zitat Peel NF, Moore DJ, Barrington NA, Bax DE, Eastell R (1995) Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 54(10):801–806PubMedPubMedCentral Peel NF, Moore DJ, Barrington NA, Bax DE, Eastell R (1995) Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 54(10):801–806PubMedPubMedCentral
40.
Zurück zum Zitat Luengo M, Picado C, Del Rio L, Guañabens N, Montserrat JM, Setoain J (1991) Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. Thorax 46(11):803–806PubMedPubMedCentral Luengo M, Picado C, Del Rio L, Guañabens N, Montserrat JM, Setoain J (1991) Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. Thorax 46(11):803–806PubMedPubMedCentral
41.
Zurück zum Zitat van Staa TP, Laan R, Barton IP, Cohen V, Reid DM, Cooper C (2003) Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 48(11):3224–3229PubMed van Staa TP, Laan R, Barton IP, Cohen V, Reid DM, Cooper C (2003) Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 48(11):3224–3229PubMed
42.
Zurück zum Zitat Kanis JA, Johansson H, Oden A, Johnell O, de Laet C, Melton C III et al (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19(6):893–899PubMed Kanis JA, Johansson H, Oden A, Johnell O, de Laet C, Melton C III et al (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19(6):893–899PubMed
44.
Zurück zum Zitat Choi YJ, Chung YS, Suh CH, Jung JY, Kim HA (2017) Trabecular bone score as a supplementary tool for the discrimination of osteoporotic fractures in postmenopausal women with rheumatoid arthritis. Medicine (Baltimore) 96(45):e8661 Choi YJ, Chung YS, Suh CH, Jung JY, Kim HA (2017) Trabecular bone score as a supplementary tool for the discrimination of osteoporotic fractures in postmenopausal women with rheumatoid arthritis. Medicine (Baltimore) 96(45):e8661
45.
Zurück zum Zitat Florez H, Hernández-Rodríguez J, Muxi A, Carrasco JL, Prieto-González S, Cid MC et al (2020) Trabecular bone score improves fracture risk assessment in glucocorticoid-induced osteoporosis. Rheumatology (Oxford) 59(7):1574–1580 Florez H, Hernández-Rodríguez J, Muxi A, Carrasco JL, Prieto-González S, Cid MC et al (2020) Trabecular bone score improves fracture risk assessment in glucocorticoid-induced osteoporosis. Rheumatology (Oxford) 59(7):1574–1580
46.
Zurück zum Zitat Confavreux CB, Chapurlat RD (2011) Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis. Osteoporos Int 22(4):1023–1036PubMed Confavreux CB, Chapurlat RD (2011) Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis. Osteoporos Int 22(4):1023–1036PubMed
47.
Zurück zum Zitat Raterman HG, Lems WF (2019) Pharmacological management of osteoporosis in rheumatoid arthritis patients: a review of the literature and practical guide. Drugs Aging 36(12):1061–1072PubMedPubMedCentral Raterman HG, Lems WF (2019) Pharmacological management of osteoporosis in rheumatoid arthritis patients: a review of the literature and practical guide. Drugs Aging 36(12):1061–1072PubMedPubMedCentral
48.
Zurück zum Zitat Finzel S, Rech J, Schmidt S, Engelke K, Englbrecht M, Stach C et al (2011) Repair of bone erosions in rheumatoid arthritis treated with tumour necrosis factor inhibitors is based on bone apposition at the base of the erosion. Ann Rheum Dis 70(9):1587–1593PubMed Finzel S, Rech J, Schmidt S, Engelke K, Englbrecht M, Stach C et al (2011) Repair of bone erosions in rheumatoid arthritis treated with tumour necrosis factor inhibitors is based on bone apposition at the base of the erosion. Ann Rheum Dis 70(9):1587–1593PubMed
49.
Zurück zum Zitat Finzel S, Rech J, Schmidt S, Engelke K, Englbrecht M, Schett G (2013) Interleukin-6 receptor blockade induces limited repair of bone erosions in rheumatoid arthritis: a micro CT study. Ann Rheum Dis 72(3):396–400PubMed Finzel S, Rech J, Schmidt S, Engelke K, Englbrecht M, Schett G (2013) Interleukin-6 receptor blockade induces limited repair of bone erosions in rheumatoid arthritis: a micro CT study. Ann Rheum Dis 72(3):396–400PubMed
50.
Zurück zum Zitat Coulson KA, Reed G, Gilliam BE, Kremer JM, Pepmueller PH (2009) Factors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) registry. J Clin Rheumatol 15(4):155–160PubMed Coulson KA, Reed G, Gilliam BE, Kremer JM, Pepmueller PH (2009) Factors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) registry. J Clin Rheumatol 15(4):155–160PubMed
51.
Zurück zum Zitat Wheater G, Elshahaly M, Naraghi K, Tuck SP, Datta HK, van Laar JM (2018) Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, results from an exploratory, prospective study. PLoS One 13(8):e0201527PubMedPubMedCentral Wheater G, Elshahaly M, Naraghi K, Tuck SP, Datta HK, van Laar JM (2018) Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, results from an exploratory, prospective study. PLoS One 13(8):e0201527PubMedPubMedCentral
52.
Zurück zum Zitat Anderson J, Caplan L, Yazdany J, Robbins ML, Neogi T, Michaud K et al (2012) Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res (Hoboken). 64(5):640–647PubMedPubMedCentral Anderson J, Caplan L, Yazdany J, Robbins ML, Neogi T, Michaud K et al (2012) Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res (Hoboken). 64(5):640–647PubMedPubMedCentral
Metadaten
Titel
Vertebral fractures are increased in rheumatoid arthritis despite recent therapeutic advances: a case-control study
verfasst von
N. Guañabens
J. M. Olmos
J. L. Hernández
D. Cerdà
C. Hidalgo Calleja
J. A. Martinez López
L. Arboleya
F. J. Aguilar del Rey
S. Martinez Pardo
I. Ros Vilamajó
X. Suris Armangué
D. Grados
C. Beltrán Audera
E. Suero-Rosario
I. Gómez Gracia
A. Salmoral Chamizo
I. Martín-Esteve
H. Florez
A. Naranjo
S. Castañeda
S. Ojeda Bruno
S. García Carazo
A. García Vadillo
L. López Vives
À. Martínez-Ferrer
H. Borrell Paños
P. Aguado Acín
R. Castellanos-Moreira
C. Tebé
C. Gómez-Vaquero
for the OsteoResSer Working Group of the Spanish Society of Rheumatology
Publikationsdatum
18.01.2021
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 7/2021
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-021-05824-7

Weitere Artikel der Ausgabe 7/2021

Osteoporosis International 7/2021 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.